HERC5
Basic information
Region (hg38): 4:88457119-88506163
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HERC5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 59 | 65 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 59 | 5 | 3 |
Variants in HERC5
This is a list of pathogenic ClinVar variants found in the HERC5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-88457364-A-G | not specified | Uncertain significance (Apr 25, 2023) | ||
4-88457365-G-T | not specified | Uncertain significance (Jan 26, 2022) | ||
4-88457416-G-C | not specified | Uncertain significance (Oct 26, 2022) | ||
4-88457459-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
4-88457496-A-G | not specified | Uncertain significance (May 18, 2023) | ||
4-88457515-C-G | not specified | Uncertain significance (Sep 14, 2022) | ||
4-88457522-G-A | not specified | Uncertain significance (Sep 26, 2023) | ||
4-88459398-C-A | not specified | Uncertain significance (Jan 06, 2023) | ||
4-88460121-A-T | not specified | Uncertain significance (Dec 22, 2023) | ||
4-88460162-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
4-88462281-G-A | not specified | Uncertain significance (Dec 16, 2022) | ||
4-88462290-A-T | not specified | Uncertain significance (Jan 26, 2022) | ||
4-88462317-A-G | not specified | Uncertain significance (Jul 11, 2023) | ||
4-88463538-A-G | not specified | Uncertain significance (Nov 30, 2022) | ||
4-88463543-C-T | not specified | Uncertain significance (Dec 06, 2023) | ||
4-88463547-C-T | not specified | Uncertain significance (Dec 13, 2023) | ||
4-88463588-G-A | not specified | Uncertain significance (Jul 13, 2022) | ||
4-88463609-G-A | not specified | Uncertain significance (Feb 28, 2023) | ||
4-88463883-G-C | not specified | Uncertain significance (Mar 08, 2024) | ||
4-88463975-G-A | Benign (Jun 02, 2018) | |||
4-88463979-G-C | Benign (Jun 02, 2018) | |||
4-88467117-A-G | not specified | Uncertain significance (Jan 17, 2024) | ||
4-88467147-C-T | not specified | Uncertain significance (Apr 25, 2023) | ||
4-88468404-G-C | not specified | Uncertain significance (Feb 16, 2023) | ||
4-88469197-A-G | not specified | Uncertain significance (Jul 14, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HERC5 | protein_coding | protein_coding | ENST00000264350 | 23 | 49047 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.68e-11 | 1.00 | 125688 | 0 | 60 | 125748 | 0.000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.845 | 444 | 497 | 0.893 | 0.0000241 | 6751 |
Missense in Polyphen | 117 | 167.37 | 0.69906 | 2325 | ||
Synonymous | 0.217 | 179 | 183 | 0.980 | 0.00000989 | 1855 |
Loss of Function | 3.23 | 25 | 49.5 | 0.505 | 0.00000210 | 686 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000351 | 0.000351 |
Ashkenazi Jewish | 0.000300 | 0.000298 |
East Asian | 0.000275 | 0.000272 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000330 | 0.000325 |
Middle Eastern | 0.000275 | 0.000272 |
South Asian | 0.000176 | 0.000163 |
Other | 0.000187 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Major E3 ligase for ISG15 conjugation. Acts as a positive regulator of innate antiviral response in cells induced by interferon. Functions as part of the ISGylation machinery that recognizes target proteins in a broad and relatively non-specific manner. Catalyzes ISGylation of IRF3 which results in sustained activation, it attenuates IRF3-PIN1 interaction, which antagonizes IRF3 ubiquitination and degradation, and boosts the antiviral response. Catalyzes ISGylation of influenza A viral NS1 which attenuates virulence; ISGylated NS1 fails to form homodimers and thus to interact with its RNA targets. Catalyzes ISGylation of papillomavirus type 16 L1 protein which results in dominant- negative effect on virus infectivity. Physically associated with polyribosomes, broadly modifies newly synthesized proteins in a cotranslational manner. In an interferon-stimulated cell, newly translated viral proteins are primary targets of ISG15. {ECO:0000269|PubMed:16407192, ECO:0000269|PubMed:16815975, ECO:0000269|PubMed:16884686, ECO:0000269|PubMed:20133869, ECO:0000269|PubMed:20308324, ECO:0000269|PubMed:20385878, ECO:0000269|PubMed:20542004}.;
- Pathway
- Cytokine Signaling in Immune system;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Innate Immune System;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Negative regulators of DDX58/IFIH1 signaling;ISG15 antiviral mechanism;Antiviral mechanism by IFN-stimulated genes;Interferon Signaling
(Consensus)
Recessive Scores
- pRec
- 0.0787
Intolerance Scores
- loftool
- 0.542
- rvis_EVS
- -0.82
- rvis_percentile_EVS
- 11.98
Haploinsufficiency Scores
- pHI
- 0.264
- hipred
- N
- hipred_score
- 0.454
- ghis
- 0.526
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.620
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- regulation of cyclin-dependent protein serine/threonine kinase activity;protein polyubiquitination;ISG15-protein conjugation;negative regulation of type I interferon production;innate immune response;regulation of defense response to virus;defense response to virus
- Cellular component
- cytosol;perinuclear region of cytoplasm
- Molecular function
- RNA binding;ubiquitin-protein transferase activity;protein binding;ISG15 transferase activity